MY157582A - Medical composition containing rebamipipe - Google Patents

Medical composition containing rebamipipe

Info

Publication number
MY157582A
MY157582A MYPI2010000374A MYPI20100374A MY157582A MY 157582 A MY157582 A MY 157582A MY PI2010000374 A MYPI2010000374 A MY PI2010000374A MY PI20100374 A MYPI20100374 A MY PI20100374A MY 157582 A MY157582 A MY 157582A
Authority
MY
Malaysia
Prior art keywords
medical composition
salt
rebamipipe
composition containing
present
Prior art date
Application number
MYPI2010000374A
Other languages
English (en)
Inventor
Yoshio Hara
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Publication of MY157582A publication Critical patent/MY157582A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MYPI2010000374A 2007-08-10 2008-08-05 Medical composition containing rebamipipe MY157582A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007209284 2007-08-10

Publications (1)

Publication Number Publication Date
MY157582A true MY157582A (en) 2016-06-30

Family

ID=39884986

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2010000374A MY157582A (en) 2007-08-10 2008-08-05 Medical composition containing rebamipipe

Country Status (7)

Country Link
JP (2) JP5328789B2 (fr)
KR (1) KR101551506B1 (fr)
CN (1) CN101778626B (fr)
AR (1) AR067887A1 (fr)
MY (1) MY157582A (fr)
TW (1) TW200918060A (fr)
WO (1) WO2009022674A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR085527A1 (es) * 2011-03-24 2013-10-09 Otsuka Pharma Co Ltd Una composicon farmaceutica para tratar una enfermedad en la cavidad oral que comprende rebamipida
JP5756727B2 (ja) * 2011-09-30 2015-07-29 ハウス食品グループ本社株式会社 顆粒
CN104768551B (zh) * 2012-07-31 2018-04-13 天主教大学产学协力团 将瑞巴派特作为有效成分而包含的高脂血症及与之相关的疾病的预防或治疗用组合物
SG11201505173RA (en) * 2012-12-28 2015-08-28 Kao Corp Dicaffeoylquinic acid-containing drink
JP6468919B2 (ja) * 2014-03-31 2019-02-13 富士フイルム富山化学株式会社 セファロスポリンエステルを含む粒状固形製剤
KR20170039347A (ko) * 2015-10-01 2017-04-11 삼진제약주식회사 레바미피드를 함유하는 신규한 점안 조성물 및 이의 제조방법
US20170295834A1 (en) * 2015-11-25 2017-10-19 Alexander LaCroix All-Natural Bitterness-Reducing Flavor System
JP7057286B2 (ja) 2016-12-28 2022-04-19 富士フイルム富山化学株式会社 医薬組成物
JP7011300B2 (ja) * 2017-12-19 2022-02-10 株式会社島田製薬 ＨＭＢＣａ含有顆粒の製造方法、及びサプリメント
KR101923519B1 (ko) * 2018-06-26 2019-02-27 대우제약 주식회사 레바미피드를 함유하는 안구 건조증 치료용 수용성 다회용 점안제 조성물 및 이의 가용화 및 안정화 방법
KR20230090185A (ko) 2021-12-14 2023-06-21 메디케어제약 주식회사 위 점막 병변을 동반한 류마티스 관절염을 치료하는 약제학적 복합제제
KR20230090184A (ko) 2021-12-14 2023-06-21 메디케어제약 주식회사 에스오메프라졸 및 레바미피드를 포함하는 약제학적 복합제제

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2839847B2 (ja) * 1993-10-21 1998-12-16 大塚製薬株式会社 インターロイキン−８産生抑制剤
JPH10306038A (ja) * 1997-05-07 1998-11-17 Taisho Pharmaceut Co Ltd ブロムヘキシン含有液剤
JP3466921B2 (ja) * 1998-06-03 2003-11-17 大塚製薬株式会社 味マスキング医薬製剤
JP3417857B2 (ja) * 1998-12-11 2003-06-16 日清オイリオ株式会社 調味料
KR20040104020A (ko) * 2003-06-02 2004-12-10 진양제약주식회사 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제
JP4244715B2 (ja) * 2003-06-12 2009-03-25 株式会社ノエビア 薬味飲料
TWI340650B (en) * 2004-01-21 2011-04-21 Otsuka Pharma Co Ltd Amine saly of carbostyril derivative
JP2005312305A (ja) * 2004-04-27 2005-11-10 Goodoo Kasei Kk 健康剤
JP4713104B2 (ja) * 2004-08-04 2011-06-29 ファイザー株式会社 アジスロマイシン類を有効成分とする苦味が抑制された安定な組成物
WO2006114918A1 (fr) * 2005-04-22 2006-11-02 Yaizu Suisankagaku Industry Co., Ltd. Agent ameliorant le gout pour aliments et boissons contenant du chlorure de potassium, procede de production d’aliments et de boissons contenant du chlorure de potassium et aliments et boissons contenant du chlorure de potassium produits par ce procede
JP4881268B2 (ja) * 2006-09-25 2012-02-22 あすか製薬株式会社 苦味が抑制された経口製剤

Also Published As

Publication number Publication date
CN101778626B (zh) 2014-05-07
WO2009022674A1 (fr) 2009-02-19
JP2013177418A (ja) 2013-09-09
AR067887A1 (es) 2009-10-28
CN101778626A (zh) 2010-07-14
TW200918060A (en) 2009-05-01
KR20100051850A (ko) 2010-05-18
KR101551506B1 (ko) 2015-09-08
JP2010535757A (ja) 2010-11-25
JP5328789B2 (ja) 2013-10-30

Similar Documents

Publication Publication Date Title
MY157582A (en) Medical composition containing rebamipipe
MX2012007375A (es) 3-ceto-n-propargil 1-aminoindano.
TN2013000253A1 (en) Bicyclo[3.2.1]octyl amide derivatives and uses of same
BR112012011072A2 (pt) inibidores de n1-pirazolospirocetona acetil-coa carboxilase
IN2012DN01233A (fr)
EA201490521A1 (ru) Варианты фактора роста фибробластов 21
MX350810B (es) Derivados de los nucleosidos sustituidos en 4 '-azido, 3 '-fluoro como inhibidores de la replicacion del rna del vhc.
SG178952A1 (en) Chemical compounds
EA201492064A1 (ru) Варианты фактора роста фибробластов 21
MX2011008634A (es) Derivados de aminotetralina composiciones farmaceuticas que los contienen y su uso en terapia.
MY151986A (en) Adamantyl diamide derivatives and uses of same
PH12015502588A1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
WO2012037562A3 (fr) Compositions pharmaceutiques et nutraceutiques d'acide abscisique
EA201291089A1 (ru) Способ получения фармацевтических препаратов, предназначенных для перорального введения, содержащих один или более активных ингредиентов, и содержащих их композиций
MX360554B (es) Composiciones que comprenden y metodos que utilizan inhibidores de co-transportadores de glucosa-sodio 1 y 2.
MY143557A (en) Beta-crystalline form of perindopril arginine salt, process for its preparation, and pharmaceutical compositions containing it
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
GEP20135832B (en) Benzothiazines derivatives, preparation thereof, and their application as drugs
DE602007014206D1 (de) Neuartige serotonin-wiederaufnahmehemmer als arzneimittel mit peripheriesystem-beschränkter aktivität
EA201000434A1 (ru) Сокристаллы пириметанила и дитианона
GEP201606514B (en) Apoptosis inhibitors and usage thereof
WO2009130422A3 (fr) N-acylthiourees et n-acylurees inhibiteurs de la voie de signalisation des proteines hedgehog
TN2012000105A1 (en) Spirolactam derivatives and uses of same
WO2009129208A8 (fr) Compositions et procédés permettant d'induire une réponse au stress du réticulum endoplasmique
BR112012009311A2 (pt) composto, composição farmacêutica, e, uso do composto